Anti-diabetic Agents and the Potentials for Reducing Cardiovascular Risks in Type-2 Diabetes Mellitus
Recent reports from Cardiovascular Outcome Trials (CVOTs) revealed that some newer anti-diabetic drugs impact Major Adverse Cardiovascular Events (MACE). These medications include the Sodium-Glucose Co-Transporter (SGLT2) inhibitors and the Glucagon-like Peptide-1 (GLP-1) receptor agonists. There is...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical and Dental Consultants Association of Nigeria, OOUTH Sagamu
2021-09-01
|
| Series: | Annals of Health Research |
| Subjects: | |
| Online Access: | https://www.annalsofhealthresearch.com/index.php/ahr/article/view/356 |